Skip to main content

ARCH Venture Partners raises $1.5B to back biotech companies

As the coronavirus crisis worsens throughout the U.S., ARCH Venture Partners just raised nearly $1.5 billion in two new funds to back biotech companies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.